EA200970598A1 - Замещенные производные гетероарилпиридопиримидона - Google Patents
Замещенные производные гетероарилпиридопиримидонаInfo
- Publication number
- EA200970598A1 EA200970598A1 EA200970598A EA200970598A EA200970598A1 EA 200970598 A1 EA200970598 A1 EA 200970598A1 EA 200970598 A EA200970598 A EA 200970598A EA 200970598 A EA200970598 A EA 200970598A EA 200970598 A1 EA200970598 A1 EA 200970598A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- group
- atom
- alkyl group
- hydrogen atom
- optionally substituted
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/90—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Dermatology (AREA)
- Obesity (AREA)
- Physical Education & Sports Medicine (AREA)
- Ophthalmology & Optometry (AREA)
- Psychiatry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Hospice & Palliative Care (AREA)
- Environmental Sciences (AREA)
- Emergency Medicine (AREA)
- Psychology (AREA)
- Heart & Thoracic Surgery (AREA)
- Agronomy & Crop Science (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Dentistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Endocrinology (AREA)
- Cardiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
Abstract
Производное пиримидона, представленное формулой (I), или его соль, или его сольват, или его гидрат, где Y представляет собой два атома водорода, атом серы, атом кислорода или Cалкильную группу и атом водорода; Z представляет собой связь, атом кислорода, атом азота, атом серы, метиленовую группу, необязательно замещенную одной или двумя группами, выбранными из Cалкильной группы, гидроксильной группы, Cалкоксигруппы, Cпергалогенированной алкильной группы или аминогруппы; R1 представляет собой 2-, 3- или 4-пиридиновое кольцо или 2-, 4- или 5-пиримидиновое кольцо; R2 представляет собой необязательно замещенную 4-15-членную гетероциклическую группу; R3 представляет собой атом водорода, Cалкильную группу или атом галогена; R4 и R5 представляют собой, каждый независимо, атом водорода, Cалкильную группу, необязательно замещенную 1-4 заместителями, выбранными из атома галогена, фенильной группы, гидроксильной группы или Cалкоксигруппы; R6 представляет собой атом водорода, Cалкильную группу, циклоалкильную группу или атом галогена; R7 представляет собой атом водорода или Cалкильную группу; n представляет собой 0-3; m представляет собой 0-1; о представляет собой 0-2; в форме свободного основания или кислотно-аддитивной соли. Настоящее изобретение относится также к лекарственному средству, включающему указанное производное или его соль в качестве активного ингредиента, которое используют для профилактики и/или терапевтического лечения нейродегенеративного заболевания, вызванного аномальной активностью GSK3β, такого как болезнь Альцгеймера.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06291995A EP1939187A1 (en) | 2006-12-20 | 2006-12-20 | Substituted heteroaryl pyridopyrimidone derivatives |
PCT/IB2007/004409 WO2008078196A2 (en) | 2006-12-20 | 2007-12-20 | Substituted heteroaryl pyridopyrimidone derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
EA200970598A1 true EA200970598A1 (ru) | 2009-12-30 |
Family
ID=38002236
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200970598A EA200970598A1 (ru) | 2006-12-20 | 2007-12-20 | Замещенные производные гетероарилпиридопиримидона |
Country Status (16)
Country | Link |
---|---|
US (1) | US8198287B2 (ru) |
EP (2) | EP1939187A1 (ru) |
JP (1) | JP2010513463A (ru) |
KR (1) | KR20090102756A (ru) |
CN (1) | CN101563328B (ru) |
AU (1) | AU2007337826A1 (ru) |
BR (1) | BRPI0721058A2 (ru) |
CA (1) | CA2672564A1 (ru) |
EA (1) | EA200970598A1 (ru) |
IL (1) | IL198524A (ru) |
MX (1) | MX2009006024A (ru) |
NO (1) | NO20092373L (ru) |
NZ (1) | NZ576894A (ru) |
TW (1) | TW200831099A (ru) |
WO (1) | WO2008078196A2 (ru) |
ZA (1) | ZA200903237B (ru) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2138492A1 (en) * | 2008-06-26 | 2009-12-30 | Sanofi-Aventis | Substituted pyrimidin-4-one derivatives |
EP2138494A1 (en) * | 2008-06-26 | 2009-12-30 | Sanofi-Aventis | Substituted alkyl pyrimidin-4-one derivatives |
DE102008038221A1 (de) | 2008-08-18 | 2010-02-25 | Merck Patent Gmbh | 7-Azaindolderivate |
DE102008038220A1 (de) | 2008-08-18 | 2010-02-25 | Merck Patent Gmbh | Oxadiazolderivate |
WO2011107494A1 (de) | 2010-03-03 | 2011-09-09 | Sanofi | Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung |
AU2011261164A1 (en) * | 2010-06-01 | 2012-12-13 | The University Of Queensland | Haematopoietic-prostaglandin D2 synthase inhibitors |
US8933024B2 (en) | 2010-06-18 | 2015-01-13 | Sanofi | Azolopyridin-3-one derivatives as inhibitors of lipases and phospholipases |
US8530413B2 (en) | 2010-06-21 | 2013-09-10 | Sanofi | Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments |
TW201215387A (en) | 2010-07-05 | 2012-04-16 | Sanofi Aventis | Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament |
TW201215388A (en) | 2010-07-05 | 2012-04-16 | Sanofi Sa | (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments |
TW201221505A (en) | 2010-07-05 | 2012-06-01 | Sanofi Sa | Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament |
WO2013037390A1 (en) | 2011-09-12 | 2013-03-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
EP2760862B1 (en) | 2011-09-27 | 2015-10-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
FR2992316A1 (fr) * | 2012-06-22 | 2013-12-27 | Sanofi Sa | Derives de pyrimidinones, leur preparation et leur application en therapeutique |
MA44007A (fr) * | 2016-02-05 | 2018-12-19 | Denali Therapeutics Inc | Inhibiteurs du récepteur interagissant avec protéine kinase 1 |
EP3497102B1 (de) | 2016-08-15 | 2022-12-07 | Bayer CropScience Aktiengesellschaft | Kondensierte bicyclische heterocyclen-derivate als schädlingsbekämpfungsmittel |
LT3552017T (lt) | 2016-12-09 | 2022-05-10 | Denali Therapeutics Inc. | Junginiai, naudotini kaip ripk1 inhibitoriai |
AU2017382339B2 (en) | 2016-12-22 | 2024-02-15 | Novartis Ag | NMDA receptor modulators and uses thereof |
CA3056886A1 (en) * | 2017-03-21 | 2018-09-27 | Arbutus Biopharma Corporation | Substituted dihydroindene-4-carboxamides and analogs thereof, and methods using same |
DK3830092T3 (en) | 2018-08-03 | 2023-08-07 | Novartis Ag | Heteroaromatic nmda receptor modulators and uses thereof |
CN109748914B (zh) * | 2018-12-29 | 2021-05-25 | 上海珂臻医药科技有限公司 | 吡啶并嘧啶类化合物及其应用 |
WO2023137035A1 (en) | 2022-01-12 | 2023-07-20 | Denali Therapeutics Inc. | Crystalline forms of (s)-5-benzyl-n-(5-methyl-4-oxo-2, 3,4,5- tetrahydropyrido [3,2-b] [l,4]oxazepin-3-yl)-4h-l,2,4-triazole-3-carboxamide |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EG13192A (en) | 1976-02-10 | 1982-12-31 | Rhone Poulenc Ind | Nouveaux derives du dithiole-1,2 leur preparation et les compositions qui les contiennent |
US5629322A (en) | 1994-11-15 | 1997-05-13 | Merck & Co., Inc. | Cyclic amidine analogs as inhibitors of nitric oxide synthase |
JP4570361B2 (ja) * | 2001-09-21 | 2010-10-27 | サノフィ−アベンティス | 置換した2−ピリミジニル−6,7,8,9−テトラヒドロピリミド[1,2−a]ピリミジン−4−オンおよび7−ピリミジニル−2,3−ジヒドロイミダゾ[1,2−a]ピリミジン−5(1H)オン誘導体 |
EP1460075A1 (en) * | 2003-03-21 | 2004-09-22 | Sanofi-Synthelabo | Substituted 8-Pyridinyl-6,7,8,9-Tetrahydropyrimido[1,2-a]Pyrimidin-4-one and 8-Phenyl-6-7,8,9-Tetrahydropyrimido[1,2-a]Pyrimidin-4-one derivatives |
EP1460076A1 (en) * | 2003-03-21 | 2004-09-22 | Sanofi-Synthelabo | Substituted 8-perfluoroalkyl-6,7,8,9-tetrahydropyrimido[1,2-a] pyrimidin-4-one derivatives |
-
2006
- 2006-12-20 EP EP06291995A patent/EP1939187A1/en not_active Withdrawn
-
2007
- 2007-12-18 TW TW096148482A patent/TW200831099A/zh unknown
- 2007-12-20 MX MX2009006024A patent/MX2009006024A/es active IP Right Grant
- 2007-12-20 KR KR1020097012761A patent/KR20090102756A/ko not_active Application Discontinuation
- 2007-12-20 NZ NZ576894A patent/NZ576894A/en not_active IP Right Cessation
- 2007-12-20 AU AU2007337826A patent/AU2007337826A1/en not_active Abandoned
- 2007-12-20 EA EA200970598A patent/EA200970598A1/ru unknown
- 2007-12-20 JP JP2009542272A patent/JP2010513463A/ja not_active Withdrawn
- 2007-12-20 EP EP07870445A patent/EP2121635A2/en not_active Withdrawn
- 2007-12-20 ZA ZA200903237A patent/ZA200903237B/xx unknown
- 2007-12-20 BR BRPI0721058-2A patent/BRPI0721058A2/pt not_active IP Right Cessation
- 2007-12-20 WO PCT/IB2007/004409 patent/WO2008078196A2/en active Application Filing
- 2007-12-20 CN CN2007800468908A patent/CN101563328B/zh not_active Expired - Fee Related
- 2007-12-20 CA CA002672564A patent/CA2672564A1/en not_active Abandoned
-
2009
- 2009-05-03 IL IL198524A patent/IL198524A/en not_active IP Right Cessation
- 2009-06-18 US US12/487,270 patent/US8198287B2/en active Active
- 2009-06-22 NO NO20092373A patent/NO20092373L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
US20090306088A1 (en) | 2009-12-10 |
US8198287B2 (en) | 2012-06-12 |
EP2121635A2 (en) | 2009-11-25 |
MX2009006024A (es) | 2009-06-30 |
IL198524A0 (en) | 2010-02-17 |
EP1939187A1 (en) | 2008-07-02 |
IL198524A (en) | 2013-03-24 |
CA2672564A1 (en) | 2008-07-03 |
WO2008078196A2 (en) | 2008-07-03 |
JP2010513463A (ja) | 2010-04-30 |
WO2008078196A3 (en) | 2008-11-06 |
CN101563328A (zh) | 2009-10-21 |
AU2007337826A1 (en) | 2008-07-03 |
NO20092373L (no) | 2009-08-28 |
ZA200903237B (en) | 2010-08-25 |
TW200831099A (en) | 2008-08-01 |
KR20090102756A (ko) | 2009-09-30 |
BRPI0721058A2 (pt) | 2014-02-25 |
CN101563328B (zh) | 2012-03-14 |
NZ576894A (en) | 2011-09-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA200970598A1 (ru) | Замещенные производные гетероарилпиридопиримидона | |
EA201170095A1 (ru) | Производные (4-пиридин-4-ил)-1h-(1,3,5) триазин-2-она в качестве ингибирования gsk3-бета для лечения нейродегенеративных заболеваний | |
EA200501315A1 (ru) | 8-ЗАМЕЩЁННЫЕ ПРОИЗВОДНЫЕ 6,7,8,9-ТЕТРАГИДРОПИРИМИДО[1,2-a]ПИРИМИДИН-4-ОНА | |
EA200501311A1 (ru) | ПРОИЗВОДНЫЕ ЗАМЕЩЁННОГО 8-ПЕРФТОРАЛКИЛ-6,7,8,9-ТЕТРАГИДРОПИРИМИДО[1,2-a]ПИРИМИДИН-4-ОНА | |
MY177250A (en) | Novel nicotinamide derivative or salt thereof | |
EA200801134A1 (ru) | Замещенные бициклические пиримидоновые производные | |
EA201070896A1 (ru) | ЗАМЕЩЕННЫЕ АРИЛАМИДДИАЗЕПИНОПИРИМИДОНОВЫЕ ПРОИЗВОДНЫЕ ДЛЯ ЛЕЧЕНИЯ НЕЙРОДЕГЕНЕРАТИВНЫХ ЗАБОЛЕВАНИЙ, ВЫЗВАННЫХ АНОМАЛЬНОЙ АКТИВНОСТЬЮ GSK3β | |
EA200601192A1 (ru) | ЗАМЕЩЁННЫЕ ПРОИЗВОДНЫЕ 8'-ПИРИ(МИ)ДИНИЛДИГИДРОСПИРО[ЦИКЛОАЛКИЛАМИН]ПИРИМИДО[1,2-a]ПИРИМИДИН-6-ОНА | |
MX2009012380A (es) | Compuestos de heteroarilamida pirimidona. | |
CY1112326T1 (el) | Παραγωγα της 6-(πυριδινυλ)-4-πυριμιδονης ως αναστολεις της κινασης 1 tau πρωτεϊνης | |
MX2010008362A (es) | Derivados de heteroarilamida diazepinopirimidona sustituidos. | |
MX2010008360A (es) | Derivados de oxazepinopirimidona heteroarilamida sustituidos. | |
EA200501241A1 (ru) | ЗАМЕЩЕННЫЕ ПРОИЗВОДНЫЕ 8'-ПИРИДИНИЛ-ДИГИДРОСПИРО-[ЦИКЛОАЛКИЛ]-ПИРИМИДО [1,2-a]ПИРИМИДИН-6-ОНА И 8'-ПИРИМИДИНИЛ-ДИГИДРОСПИРО-[ЦИКЛОАЛКИЛ]-ПИРИМИДО [1,2-a]ПИРИМИДИН-6-ОНА И ИХ ПРИМЕНЕНИЕ В ЛЕЧЕНИИ НЕЙРОДЕГЕНЕРАТИВНЫХ ЗАБОЛЕВАНИЙ | |
ATE543803T1 (de) | 3-ä2-(3-azylamino-2-oxo-2h-pyridin-1- yl)acetylaminoü-4-oxopentansäurederivate und deren verwendung als caspase-inhibitoren | |
EA201170094A1 (ru) | Производные замещенного пиримидо[2,1-а]изохинолин-4-она | |
EA200970455A1 (ru) | ЗАМЕЩЕННЫЙ 8-ПИПЕРИДИНИЛ-2-ПИРИДИНИЛПИРИМИДО[1,2-a]ПИРИМИДИН-6-ОН И ПРОИЗВОДНЫЕ 8-ПИПЕРИДИНИЛ-2-ПИРИМИДИНИЛПИРИМИДО[1,2-a]ПИРИМИДИН-6-ОНА | |
MX2009006947A (es) | Derivados de pirimidona 6-heterociclica 2-sustituida. | |
EA200971060A1 (ru) | Гетероариламидные пиримидоновые производные | |
ATE388939T1 (de) | N-((piperazinyl)hetaryl)arylsulfonamid-derivate mit affinität zum dopamin-d3-rezeptor | |
RU2007122499A (ru) | Новые производные пиридонкарбоновой кислоты или их соли | |
CY1113801T1 (el) | Παραγωγο κιναζολινης και φαρμακευτικο ειδος | |
ATE488512T1 (de) | Piperazinderivate als ccr3-hemmer | |
TH99137B (th) | อนุพันธ์เฮทเทโรแอริลพิริโดพิริมิโดนที่ถูกแทนที่ | |
TH99137A (th) | อนุพันธ์เฮทเทโรแอริลพิริโดพิริมิโดนที่ถูกแทนที่ | |
AR064445A1 (es) | Derivados de heteroaril piridopirimidona sustituidos. composiciones farmaceuticas |